4//SEC Filing
Garner Elizabeth 4
Accession 0001209191-23-043433
CIK 0001645666other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 5:01 PM ET
Size
20.6 KB
Accession
0001209191-23-043433
Insider Transaction Report
Form 4
Garner Elizabeth
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-07-24−17,793→ 0 totalExercise: $3.03Exp: 2029-12-17→ Common Stock (17,793 underlying) - Award
Stock Option (Right to Buy)
2023-07-24+17,793→ 17,793 totalExercise: $2.28Exp: 2029-12-17→ Common Stock (17,793 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-24−26,000→ 0 totalExercise: $5.59Exp: 2031-06-27→ Common Stock (26,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-24−8,896→ 0 totalExercise: $5.60Exp: 2030-06-23→ Common Stock (8,896 underlying) - Award
Stock Option (Right to Buy)
2023-07-24+8,896→ 8,896 totalExercise: $2.28Exp: 2030-06-23→ Common Stock (8,896 underlying) - Award
Stock Option (Right to Buy)
2023-07-24+26,000→ 26,000 totalExercise: $2.28Exp: 2031-06-27→ Common Stock (26,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-24−26,000→ 0 totalExercise: $4.80Exp: 2032-06-15→ Common Stock (26,000 underlying) - Award
Stock Option (Right to Buy)
2023-07-24+26,000→ 26,000 totalExercise: $2.28Exp: 2032-06-15→ Common Stock (26,000 underlying)
Footnotes (2)
- [F1]Fully vested and exercisable.
- [F2]On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001608578
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 5:01 PM ET
- Size
- 20.6 KB